methyl [N-benzyl-benzyloxycarbonyl-5-aminopentyl (2,7-di-O-acetyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→5)-4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid]onate | 1403362-18-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl [N-benzyl-benzyloxycarbonyl-5-aminopentyl (2,7-di-O-acetyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→5)-4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid]onate
• CAS: 1403362-18-4
• 化学式: C₆₄H₇₆BrNO₁₈
• 分子量: 1227.21
• InChiKey: HLYVVODMWUHMAD-FDYCQIDOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.31
• 重原子数：
  84.0
• 可旋转键数：
  28.0
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  211.74
• 氢给体数：
  1.0
• 氢受体数：
  18.0

反应信息

• 作为反应物：
  描述：

  methyl [N-benzyl-benzyloxycarbonyl-5-aminopentyl (2,7-di-O-acetyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→5)-4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid]onate 、 (N-phenyltrifluoroacetimidoyl) (2-O-acetyl-3,7-di-O-benzoyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→7)-2,6-di-O-benzyl-3-O-levulinoyl-4-O-para-bromobenzyl-L-glycero-D-manno-heptopyranoside 在 三氟甲磺酸三甲基硅酯 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 1.0h， 以67%的产率得到methyl [5-(N-benzyl-benzyloxycarbonylamino)pentyl (2-O-acetyl-3,7-di-O-benzoyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-Dmanno-heptopyranosyl)-(1→7)-(2,6-di-O-benzyl-3-O-levulinoyl-4-O-para-bromobenzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→3)-(2,7-di-O-acetyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→5)-4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid]onate
  参考文献：
  名称：

  Diversity-oriented Synthesis of Inner Core Oligosaccharides of the Lipopolysaccharide of Pathogenic Gram-negative Bacteria

  摘要：

  Lipopolysaccharide (LPS) is a potent virulence factor of pathogenic Gram-negative bacteria. To better understand the role of L,PS in host-pathogen interactions and to elucidate the antigenic and immunogenic properties of LPS inner core region, a collection of well-defined L-glycero-D-manno-heptose (Hep) and 3-deoxy-alpha-D-manno-oct-2-ulosonic acid (Kdo)-containing inner core oligosaccharides is required. To address this need, we developed a diversity-oriented approach based on a common orthogonal protected disaccharide Hep-Kdo. Utilizing this new approach, we synthesized a range of LPS inner core oligosaccharides from a variety of pathogenic bacteria including Y. pestis, H. influenzae, and Proteus that cause plague, meningitis, and severe wound infections, respectively. Rapid access to these highly branched core oligosaccharides relied on elaboration of the disaccharide Hep-Kdo core as basis for the elongation with various flexible modules including unique Hep and 4-amino-4-deoxy-beta-L-arabinose (Ara4N) monosaccharides and branched Hep-Hep disaccharides. A regio- and stereoselective glycosylation of Kdo 7,8-diol was key to selective installation of the Ara4N moiety at the 8-hydroxyl group of Kdo moiety of the Hep-Kdo disaccharide. The structure of the LPS inner core oligosaccharides was confirmed by comparison of H-1 NMR spectra of synthetic antigens and isolated fragments. These synthetic LPS core oligosaccharides can be covalently bound to carrier proteins via the reducing end pentyl amine linker, to explore their antigenic and immunogenic properties as well as potential applications such as diagnostic tools and vaccines.

  DOI：

  10.1021/ja401164s
• 作为产物：
  描述：

  methyl [N-benzyl-benzyloxycarbonyl-5-aminopentyl (2,7-di-O-acetyl-3-O-levulinoyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→5)-4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid]onate 在 乙酸肼 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.67h， 以73%的产率得到methyl [N-benzyl-benzyloxycarbonyl-5-aminopentyl (2,7-di-O-acetyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→5)-4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid]onate
  参考文献：
  名称：

  Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis

  摘要：

  本发明涉及从脑膜炎奈瑟氏菌的脂多糖中全合成α-GlcNAc-(1→2)-α-Hep-(1→3)-α-Hep-(1→5)-α-Kdo核心四糖，所得的产物以及α-GlcNAc-(1→2)-α-Hep-(1→3)-α-Hep-(1→5)-α-Kdo用作疫苗，用于预防由含有四糖的细菌感染引起的疾病，特别是用于预防由脑膜炎奈瑟氏菌引起的脑膜炎、败血症、肺炎和鼻咽炎的免疫。

  公开号：

  EP2573100A1